1. Trang chủ
  2. » Luận Văn - Báo Cáo

Báo cáo khoa học: Mapping of chorismate mutase and prephenate dehydrogenase domains in the Escherichia coli T-protein doc

7 337 0
Tài liệu đã được kiểm tra trùng lặp

Đang tải... (xem toàn văn)

THÔNG TIN TÀI LIỆU

Thông tin cơ bản

Định dạng
Số trang 7
Dung lượng 178,64 KB

Các công cụ chuyển đổi và chỉnh sửa cho tài liệu này

Nội dung

The 373 amino acid T-protein is a homodimer that exhibits chorismate mutase CM and prephenate dehydrogenase PDH activities, both of which are feedback-inhibited by tyrosine.. Enzyme assa

Trang 1

Mapping of chorismate mutase and prephenate dehydrogenase

Shuqing Chen1,*, Sarah Vincent2, David B Wilson1and Bruce Ganem2

1

Department of Molecular Biology and Genetics and2Department of Chemistry and Chemical Biology, Cornell University, NY, USA

The Escherichia coli bifunctional T-protein transforms

chorismic acid to p-hydroxyphenylpyruvic acid in the

L-tyrosine biosynthetic pathway The 373 amino acid

T-protein is a homodimer that exhibits chorismate mutase

(CM) and prephenate dehydrogenase (PDH) activities, both

of which are feedback-inhibited by tyrosine Fifteen genes

coding for the T-protein and various fragments thereof were

constructed and successfully expressed in order to

charac-terize the CM, PDH and regulatory domains Residues 1–88

constituted a functional CMdomain, which was also

dimeric Both the PDH and the feedback-inhibition activities

were localized in residues 94–373, but could not be separated into discrete domains The activities of cloned CMand PDH domains were comparatively low, suggesting some cooper-ative interactions in the ncooper-ative state Activity data further indicate that the PDH domain, in which NAD, prephenate and tyrosine binding sites were present, was more unstable than the CMdomain

Keywords: chorismate mutase; E coli T-protein; prephenate dehydrogenase

The final step in the biosynthesis of tyrosine in Escherichia

coli and other enteric bacteria is the transamination of

p-hydroxyphenylpyruvate, which is produced in two

sequential chemical reactions from chorismic acid in

nature’s shikimic acid metabolic pathway [1,2] In the first

reaction, chorismate undergoes a Claisen rearrangement to

form prephenate, which is catalyzed by chorismate mutase

(CM; EC 5.4.99.5) In the second reaction, prephenate

undergoes NAD+-mediated oxidative decarboxylation to

p-hydroxyphenylpyruvate, which is catalyzed by prephenate

dehydrogenase (PDH; EC 1.3.1.12) In E coli, both the

CMand PDH activities are located in a single, bifunctional

protein known as the T-protein, which is encoded by the

tyrA gene Tyrosine (Tyr) is an end product inhibitor of

both CMand PDH, and induces aggregation of the

T-protein [3] An analogous bifunctional protein in E coli,

known as the P-protein, contains CMand prephenate

dehydratase (PDT), and catalyzes the transformation of

chorismate into phenylpyruvate in the biosynthetic pathway

to phenylalanine

Domain mapping studies on the P-protein (386 amino

acids, homodimer, molecular mass 43 kDa) have

estab-lished that the CM, PDT, and regulatory activities reside

in discrete, separable domains that can be subcloned and expressed [4–7] The structure of the P-protein CM domain (residues 1–109), which has been solved by X-ray crystallography, reveals the key structural motif respon-sible for noncovalent dimer formation in the wild-type protein However, biochemical studies aimed at mapping the various functional domains in the T-protein suggest a more complex spatial relationship of the catalytic sites Primary sequence alignments between the T- and P-proteins indicate that CMin the T-protein is also located at the N-terminus, although the sequences share only approximately 25% similarity Mutagenesis studies

on the T-protein and kinetic studies using substrate analogs suggested that the CMand PDH reactions occurred at overlapping [8] or perhaps closely proximal [9] active sites Strong evidence for two separate CMand PDH active sites comes from pH rate profile analyses [10] and from various substrate and product-based inhibitors that affect the two catalytic activities with differing degrees of selectivity [11] At one extreme, a widely studied oxabicyclic mutase inhibitor has been shown to inhibit CMactivity in the T-protein without affecting PDH activity [9] More recently, a tricyclic diacid was reported to inhibit PDH activity in the T-protein without affecting CMactivity [12]

The main objectives of this study were to investigate the various domain substructures, interactions, and allos-teric effects in the E coli T-protein by genetically engineering and expressing fragments of tyrA Using these techniques, we hoped to determine whether the CM and PDH activities could be separated into discrete, properly folded entities displaying good catalytic activity

We also hoped to ascertain whether a separate regulatory domain existed within the T-protein that was responsible for Tyr-induced end-product inhibition and T-protein aggregation Finally, we hoped to gain an understanding

Correspondence to B Ganem, Department of Chemistry

and Chemical Biology, Baker Laboratory, Cornell University,

Ithaca, NY 14853-1301 USA.

Fax: + 1 607 255 6318, Tel.: + 1 607 255 7360,

E-mail: bg18@cornell.edu

Abbreviations: CM, chorismate mutase; PDT, prephenate

dehydra-tase; PDH, prephenate dehydrogenase; WT, wild-type.

Enzymes: chorismate mutase (EC 5.4.99.5); prephenate

dehydrogenase (EC 1.3.1.12).

*Present address: College of Pharmaceutical Science,

Zhejiang University, Hangzhou 310031, P.R China.

(Received 25 October 2002, revised 11 December 2002,

accepted 19 December 2002)

Trang 2

of the detailed molecular interactions involved in

T-protein dimerization

Experimental procedures

Materials

Unless indicated otherwise, all chemicals and biochemicals

were purchased from Sigma, and enzymes were purchased

from New England Biolabs

Strain

E coliBL21 Gold (DE3) competent cells (Stratagene) were

used as the host for cloning, plasmid preparation and

protein expression

Recombinant DNA method

The tyrA gene, which codes for the T-protein, was

subcloned from plasmid pKB45, a derivative of pMB9

that contains a 6-kb segment of E coli chromosomal

DNA [13] Several primers (Table 1) were used to

amplify specific fragments from pKB45 NdeI and XhoI

sites were introduced into the primers at the N- and

C-terminal coding sites, respectively, of the target

fragments A His tag was attached to the C-terminus

of the wild-type (WT) T-protein as a means of

simplifying the previously reported isolation [14] and

purification [15] procedures C-terminal His-tags were

also attached to each fragment to facilitate subsequent

purification In order to promote the fidelity of PCR,

GC-rich PCR kits were employed in amplification

DNA sequencing (Cornell BioResource Center) was

carried out on every new plasmid to confirm that no

mutations had been introduced by PCR Novagen

pET26b+ was used as the vector for all cloning It

has a kanamycin-resistant gene to facilitate screening for

transformants

Expression

All strains harboring plasmids were grown in LB (Luria–

Bertani) medium or on LB plates containing kanamycin

(60 lgÆmL)1) All strains were grown in LB containing

kanamycin (60 lgÆmL)1) at 37C for seed cultures and in

LB without antibiotics inoculated 1 : 50 for large-scale

enzyme production

Isolation and purification of the T-protein and cloned fragments thereof

After induction with 1 mMisopropyl b-D-thiogalactoside at

D660¼ 0.8 and growth at 30 C for 2.5 h, cells were collected by centrifugation at 10 000 g at 4C for 25 min Cell pellets were resuspended in cold binding buffer (5 mM

imidazole, 0.5MNaCl, 20 mMTris/HCl, pH 7.9), and the cells were ruptured at 2000 p.s.i using a French press Purification of the intact, His-tagged T-protein and of its cloned fragments was performed on His-tag resin (Novagen) following the manufacturer’s protocol Peptide 1–88, without a His-tag, was obtained by mutating residue

89 to create a stop codon The expressed peptide was purified by Q-Sepharose and Ultragel ACA54 column chromatography

Proteolytic digestion The purified T-protein was partly digested with papain by varying the time and quantity of papain T-protein (20 lg) was dissolved in 100 lL of 0.1M NH4Ac, 0.004M EDTA, 0.01M cysteine (pH 6.8) and 0.4 lL of 0.1 mgÆmL)1 (1 : 50 ratio) or 2 lL of 0.01 mgÆmL)1 (1 : 1000 ratio) of papain were added The reaction was incubated at 37C and 10 lL samples were removed into tubes containing SDS gel loading buffer and put into a boiling water bath for 3 min at 0, 15, 30, 45, 60, 90, and

120 min intervals All samples were then run on SDS/ PAGE gels

Enzyme assays Chorismate mutase and prephenate dehydrogenase activity assays were performed according to Davidson et al [14] with 1 mM chorismate or 0.2 mM prephenate and 2 mM

NAD, respectively One unit of enzyme was defined as the amount of enzyme required to produce 1 lmol of product per minute at 37C Specific activity was expressed as units per mg of protein

Kinetic studies Enzyme assays of the T-protein and derived fragments in the presence of Tyr were run at effector concentrations from

0 to 0.3 mM, with substrate concentrations ranging from 0

to 1 mMor 2 mMbased on the Kmvalue to be measured Controls were run for every assay Values for the maximal

Table 1 Primers used to clone T-protein peptides.

Primer Sequence

T01 5¢-GGT AGA CTC GAG TCA GTG GTG GTG GTG GTG GTG CTG GCG ATT GTC ATT CGC CTG ACG C-3¢ T02 5¢-GCT TAA GAG GTT TCA TAT GGT TGC TGA ATT G-3¢

PDH96 5¢-GGA TTT AAA ACA CAT ATG CCG TCA CTG CGT CCG GTG-3¢

PDH93 5¢-CGA CAA AGG ACA TAT GCA ACT TTG TCC GTC ACT GCG-3¢

PDH101 5¢-CCG TCA CTG CAT ATG GTG GTT ATC GTC GGC G-3¢

PDH93-336 5¢-CCA GTG CTC CAC CTC GAG TCA GTG GTG GTG GTG GTG GTG CTT ATC GCC CTG CTC CAG CAA-3¢ PDH93-316 5¢-CAA CTC AAT CGC CTC GAG TCA GTG GTG GTG GTG GTG GTG GAT TAA CGC CAG ATT ACG CTC TG-3¢ PDH93-296 5¢-GCT CTG ACG ACA TAA TCT CGA GTC AGT GGT GGT GGT GGT GGT GAG CCA ACA GTC GCC CGA CC-3¢ PDH93-276 5¢-CAT CGC CAG CTC AAG CTC GAG TCA GTG GTG GTG GTG GTG GTG AAG TTG CTC AAG CTG AAC AT-3¢ CM1-94 5¢-GCC ACC GCC GAC CTC GAG TCA GTG GTG GTG GTG GTG GTG AAG TGT TTT AAA TCC TTT GTC-3¢ CM1-108 5¢-CGA GAG GGT CAG CTC GAG TCA GTG GTG GTG GTG GTG GTG ACC GCC ACC GCC GAC GAT-3¢

Trang 3

velocity (Vmax) and the Michaelis constant (Km) were

determined using standard rate equations in conjunction

with the curve fitting options in theKALEIDAGRAPHprogram

(Abelbeck Software)

N-terminal analysis

Samples of the proteolytic bands were prepared for

N-terminal sequencing by electroblotting from the SDS

gels after electrophoresis An Immobilen-P membrane was

prewet in methanol, and electrotransfer was performed

following the manufacturer’s procedure (50 V, 1 h)

Membranes were stained with 0.1% Commassie bright

blue for 10 min and destained in 90% methanol, 7%

acetic acid to a clear background The band was cut out

and N-terminal sequencing was performed on a PE/

Applied Biosystems Procise 492 by the Cornell

Bio-Resource Center

Molecular mass estimation

Molecular masses were determined by SDS gel

electro-phoresis under denatured conditions and gel exclusion

HPLC for determination of native molecular masses

Standard molecular mass markers (Invitrogen BenchMark

Prestained Protein Ladder) were run on 12% or 17% SDS/

PAGE gels A 600E Waters HPLC was used with a

Pak Glass 300SW 8· 300 mm column and 50 mM Tris/

HCl, pH 8.0, 50 mM NaCl buffer at a flow rate of

0.75 mLÆmin)1 A Bio-Rad gel filtration standard was used

to prepare a standard curve

Chemical cross-linking

The C-terminal His-tagged T-protein was chemically

cross-linked by a modified procedure as follows: 0.05 mg of

T-protein was dissolved in 20 mL of 50 mM KH2PO4/

K2HPO4 buffer (pH 6.0), and 50% glutaraldehyde

(0.83 mL) was added to give a final concentration of 2%

The reaction was run at room temperature for 22 h, then

0.5 mL of freshly prepared 2MNaBH4/0.1MNaOH was

added to quench the reaction After standing at room

temperature for 20 min, 20 lL of 10% sodium

deoxycho-late in 0.1MNaOH was added followed by 0.5 mL of 100%

trichloroacetic acid (w/v) and the mixture was incubated

until the deoxycholate and protein precipitated The

sam-ples were centrifuged at 20 000 g for 20 min and the pellets

were immediately dissolved in SDS/PAGE loading buffer

containing dithiothreitol, boiled for 3 min and analyzed by

electrophoresis on SDS/PAGE, using 17% acrylamide

gels for proteins having molecular mass < 20 kDa and

12% acrylamide gels for proteins having molecular

mass > 20 kDa

Results

Expression

Expression levels for all fragments lacking the native

N-terminal sequence (plasmids PSQC2,3,4,5,6,7,8,13)

were low Good levels of expression were observed with all

other fragments By working at lower temperature (30C),

the formation of inclusion bodies was suppressed, and expressed fragments were isolated from the soluble fractions Activity of wild-type T-protein

In assays of the WT T-protein, the specific activity for CM was 130 unitsÆmg protein)1, and that for PDH was

98 unitsÆmg protein)1(Table 3) Both values were in good agreement with those determined by Davidson et al [13] However, prolonged storage of purified His-tagged T-protein at )80 C, whether in storage buffer (0.1M

sodium citrate : 10% glycerol : 1 mMdithiothreitol, pH 7.5)

or in assay buffer (0.1MMes, 0.051MN-ethylmorpholine, 0.01Mdiethanolamine, 1 mMEDTA, 1 mMdithiothreitol, 10% glycerol, pH 7.5) resulted in the loss of virtually all PDH activity (Fig 1) Activity losses were somewhat smaller when protein was stored in the assay buffer Because

of the instability of the T-protein, all assays were performed

on fresh enzyme Controls indicated negligible loss of activity on the day that assays were conducted The specific activity values reported in Table 3 were relative to freshly prepared enzyme (100% activity), and represented the highest values determined from the initial assays

Proteolysis studies When papain was used to digest the T-protein under limiting conditions (papain : T-protein¼ 1 : 1000), a con-sistent pattern of fragments was detected having molecular mass values centered around 30 kDa and 10 kDa (Fig 2) The N-terminal sequence of the 30 kDa fragment was determined to be TLCPSLRPVVIV, which corresponded to residues 93–104 of the T-protein Essentially identical results were obtained when the T-protein was digested in the presence of Tyr (300 lM), but without NAD+

Digestions carried out in the presence of higher con-centrations of papain (papain : T-protein¼ 1 : 50) for limited periods of time revealed that the 30 kDa fragment

Fig 1 CM and PDH activity lost during storage.

Trang 4

disappeared almost completely within 30 min, while the

10 kDa fragment was still detectable after 60 min (Fig 3)

Activity of cloned T-protein fragments

Guided by the proteolysis results and using appropriately

selected primer pairs, 14 new plasmids (Table 2) were

constructed and used to express T-protein fragments

corresponding to various regions of the T-protein

sequence The expressed proteins were designated with

abbreviations indicating their T-protein origin and

inclu-sive residues

The specific activities of both CMand PDH were

determined for all engineered T-protein fragments

(Table 3) The data indicate that all peptides containing

the N-terminal 88 residues of the T-protein (entries 9–15)

exhibited CMactivity However, the specific activity of all

CM-active T-protein fragments was low Even the largest

such fragment, T/1–336, exhibited only approximately 5%

of the native T-protein’s activity The Michaelis constant,

Km for CMactivity in T/1–88 and T/1–336 were

1.7 ± 0.1 mM and 2.4 ± 0.5 mM, respectively By

com-parison, Kmfor the T-protein was 0.23 mM None of the

fragments exhibiting CMactivity displayed PDH activity

T-protein fragments T/93–373 and T/96–373 (Table 3,

entries 2 and 3) retain 25–50% of the PDH activity of the

T-protein, but are devoid of CMactivity Fragment T/101–373 lacked PDH activity suggesting that residues 97–100 of the T-protein were essential for it (Table 3) Several additional T-protein fragments were studied (Table 3, entries 4–8) to refine the site of PDH activity Fragments T/101–373, T/93–277, T/93–297, T/93–316, and T/93–336 displayed neither CMactivity nor PDH activity Expression levels of the truncated proteins in Table 3 entries 2–8 were significantly lower than for proteins in entries 9–15, which retained the native N-terminus Feedback inhibition by Tyr

In the absence of NAD+, the CMactivity of fragments T/1–88, T/1–94 and T/1–108 was unaffected by Tyr at concentrations up to 300 lM The CMactivity of fragment

Table 2 Primer pairs used in constructing plasmids for cloning T-protein fragments.

Plasmid Primer

T-protein fragment PSQC1 T02, T01 T/1–373

(T-protein) PSQC2 PDH93, T01 T/93–373 PSQC3 PDH96, T01 T/96–373 PSQC4 PDH101, T01 T/101–373 PSQC5 PDH93, PDH93-276 T/93–277 PSQC6 PDH93, PDH93-296 T/93–297 PSQC7 PDH93, PDH93-316 T/93–316 PSQC8 PDH93, PDH93-336 T/93–336

pSQC9 T02, CM1-94 T/1–94 pSQC10 T02, CM1-108 T/1–108 pSQC11 T02, PDH93-276 T/1–276 pSQC12 T02, PDH93-296 T/1–296 pSQC13 T02, PDH93-316 T/1–316 pSQC14 T02, PDH93-336 T/1–336

Fig 2 Proteolytic digestion ofthe T-protein by papain at a ratio of

1 : 1000 (w/w) Lane 1, molecular mass standards; lane 2, 0 min; lane

3, 15 min; lane 4, 30 min; lane 5, 45 min; lane 6, 60 min; lane 7,

90 min; lane 8, 120 min.

Fig 3 The proteolytic digestion ofT-protein by papain at a ratio of

papain/T-protein ¼ 1 : 50 (w/w) Lane 1, 0 min (enzyme added; some

digestion observed); lane 2, 30 min; lane 3, 60 min; lane 4, molecular

mass ladder.

Table 3 CM and PDH activities ofcloned segments ofthe T-protein.

Enzyme activity (UÆmg)1) Entry Plasmids Protein fragment CMPDH

1 PSQC1 T/1–373 (T-protein) 130 98

2 PSQC2 T/93–373 0 25.2

3 PSQC3 T/96–373 0 55.0

4 PSQC4 T/101–373 0 0

5 PSQC5 T/93–277 0 0

6 PSQC6 T/93–297 0 0

7 PSQC7 T/93–316 0 0

8 PSQC8 T/93–336 0 0

9 pSQC24 T/1–88 1.8 0

10 pSQC9 T/1–94 11.4 0

11 pSQC10 T/1–108 8.1 0

12 pSQC11 T/1–276 10.1 0

13 pSQC12 T/1–296 7.9 0

14 pSQC13 T/1–316 9.2 0

15 pSQC14 T/1–336 8.8 0

Trang 5

T/1–336 was mildly elevated in the presence of Tyr at

concentrations up to 10 lM In contrast, the PDH activity in

fragments T/93–373 and 96/373 was inhibited in the

presence of Tyr, with 50% inhibition of activity in each

protein fragment observed at 25 ± 5 lMTyr

Molecular mass estimation and subunit

association analysis

The calculated molecular mass values for T/1–94 (12.5 kDa)

and T/1–108 (14 kDa) agreed well with values obtained

from SDS/PAGE using standard molecular mass markers

(data not shown) Gel exclusion HPLC analysis was used to

identify the molecular mass of the two fragments under

native conditions Using a standard curve based on the

retention times and log molecular masses of four known

proteins (Table 4), molecular masses for T/1–94 and T/93–

373 were calculated to be 25 kDa and 63 kDa, respectively,

indicating that both fragments were dimers

As the molecular mass of the T-protein exceeded the

effective range of gel exclusion HPLC analysis, chemical

cross-linking was used to identify the state of the T-protein

under native conditions (Fig 4) SDS/PAGE analysis after

cross-linking indicated that the native T-protein was a

dimer, having a molecular mass of 85 kDa

Discussion

The E coli T- and P-proteins share numerous structural

and kinetic similarities Besides being native dimers

(com-posed of subunits of similar Mrvalues), both bifunctional catalysts are subject to end-product inhibition (by Tyr and Phe, respectively) induced by the aggregation of dimers into higher oligomers Feedback inhibition in each case more strongly affects the second, prephenate-processing, enzyme (PDH and PDT, respectively)

Several lines of evidence indicate that the major difference between the T- and P-proteins is the spatial and functional relationship between the two catalytic activities in each bifunctional enzyme Earlier studies from these laboratories established that the CM, PDT, and regulatory functions of the E coli P-protein reside in discrete, separable domains that can be subcloned and expressed [5] In the case of the E coli T-protein, several previous kinetic studies suggested interdependent, and perhaps overlapping [8] or closely proximal [9], CMand PDH active sites The interdependence of the catalytic sites

in the T-protein was first noted by Koch et al who compared the rates of the CMand PDH reactions and observed a distinct lag phase in the latter process [16] Furthermore, levels of free prephenate accumulating in the reaction mixture could not account for the observed rate

of the PDH reaction, further suggesting interactions between the CMand PDH sites Koch et al also observed that the inhibition constant (Ki) for prephenate closely paralleled its Km value for the PDH reaction, and concluded that the CMand PDH-catalyzed reactions shared a common prephenate binding site on the T-protein Subsequently, Heyde and Morrison noted that NAD+, the cofactor required for PDH activity, also boosted CMactivity, while chorismate enhanced PDH activity [8]

The present study represents the first systematic effort to identify amino acid sequences within the T-protein that, when expressed as discrete fragments, displayed either CM

or PDH activity The main goal of the study was to learn whether CMor PDH activity might be separated into individual domains of the T-protein A further goal of the study was to ascertain whether feedback inhibition by Tyr might also involve a discrete region of the T-protein The established domain relationships in the P-protein suggested that a T-protein fragment embodying the N-terminus and the first 90–100 residues might exhibit CMactivity A modest level of sequence similarity (22 of the first 56 residues are identical [2]) in the N-terminal regions of the T- and P-proteins further supported this conclusion, although potential differences in secondary structure between the two proteins complicated any analysis based strictly on sequence comparison The results of limited digestion of the T-protein using papain consistently affor-ded a pattern of fragments having principal bands at molecular masses 10 and 30 kDa N-terminal sequence analysis indicated that the two fragments corresponded to residues 1–92 and 93–373, respectively The finding that the smaller, 10 kDa fragment was somewhat resistant to proteolysis (Fig 3) also lent credence to the possibility that

it existed as a separately folded domain in the T-protein The T-protein has been reported to be quite unstable in crude cell extracts [17], although stabilization of pure T-protein by prephenate or Tyr has been noted [16] Heyde and Morrison observed that the T-protein exhibited poor stability when stored in dilute solution, causing the ratio of

Fig 4 The T-protein was cross-linked by 2% glutaraldehyde at

2.5 lgÆmL)1ofT-protein for 22 h Lane 1, ladder; lane 2, T-protein

control; lane 3, T-protein after cross-linking.

Table 4 HPLC retention times and molecular masses ofT-protein

fragments and standards.

Protein

Retention time (min)

Molecular mass (kDa)

Aggregation state

Chicken ovalbumin 11.8 44 –

Equine myoglobin 15.3 17 –

CM1-94 13.2 25 Dimer

PDH93-373 11.0 63 Dimer

Trang 6

CMto PDH activity to vary from 0.8 to 1.2 between

preparations [8] It should be noted that the E coli

T-protein has been reported to be quite sensitive to both

storage and aging [18]

The present study used T-protein expressed with a

C-terminal His-tag to simplify purification Chemical

cross-linking experiments confirmed its dimeric structure

under native conditions (Fig 4) and its catalytic profile

matched the wild-type protein However, the stability of

the His-tag labelled T-protein remained a problem PDH

activity deteriorated particularly rapidly during storage

(Fig 1), whereas significant levels of CMactivity were

retained Taken together with results from limited

proteo-lysis experiments, the data suggested that the region of the

T-protein associated with PDH catalysis was more loosely

packed, and hence more easily denatured, than the

corres-ponding domain or residues associated with CMactivity

His-tagged forms of the E coli T-protein and 14

fragments thereof were successfully expressed and purified

by affinity chromatography Screening of those fragments

for enzymatic activity (Table 3) indicated that neither the

CMnor the PDH active site could be expressed in fully

functional form as a discrete, contiguous subregion of the

T-protein Based on the seven fragments that displayed

CMactivity, residues 1–88 appeared to be essential for CM

catalysis While CMactivity was enhanced by including the

additional residues, 89–94, the most active fragment

displayed only 8% of WT T-protein activity Surprisingly,

a stepwise increase in the fragment length (T/1–108, T/1–

276, T/1–296, T/1–316, T/1–336) did not increase CM

activity

Several possible explanations were considered for the

consistently low levels of mutase activity The association of

engineered fragments into homodimers, shown to be

important in the monofunctional mutase derived from the

E coliP-protein, was confirmed in the case of T/1–94 by gel

exclusion HPLC (Table 3) Contamination of the purified

fragments by low levels of WT T-protein was ruled out by

the absence of any corresponding PDH activity (Table 3) If

the organization of the CMand PDH/PDT active sites in

the T and P-proteins were similar, then a heterodimeric

enzyme displaying CMbut not PDH activity might

plausibly arise by the complexation of one His-tagged

fragment with one WT T-protein chain This possibility

seemed remote for two reasons Because the cloned

fragment was expressed at much higher concentrations

compared to the native T-protein, any suspect heterodimer

would have represented a very small amount of the protein

Moreover, analysis of each mutase-active fragment by

SDS/PAGE at high gel loading levels revealed no higher

molecular mass band matching the T-protein or

corres-ponding heterodimer

The low mutase activity of the N-terminal fragments

(Table 3) indicated that a discrete, fully active CM

subdomain comprising contiguous T-protein residues

could not be expressed, showing that a catalytically

efficient CMactive site required most, if not all, of the

T-protein An earlier report by Christendat et al [15]

indicated that mutagenesis of several residues in the

dehydrogenase portion of the T-protein significantly

affected CMactivity, either by reducing Kcat(His189Asn)

or elevating K (His239Asn, His245Asn) The findings

reported here suggest that additional amino acids in the PDH domain, extending beyond residue 336 effect mutase activity

Proper CMfunction may be disrupted by poor substrate binding, as has been noted with the His239 and His245 mutants Likewise, the series of N-terminal fragments (entries 9–15, Table 3) may have structurally altered or incomplete PDH substrate binding sites that cause poor substrate binding If, as has been suggested [16], prephenate undergoes transfer from the product-binding pocket of the CMsite to the substrate-binding pocket of the PDH site, then the weak CMactivity of the CMfragments might be due to slow product release or trapping of prephenate on the truncated protein

In contrast, fragments of the T-protein could be prepared that contained catalytically competent, monofunctional dehydrogenases with the requisite NAD+ binding sites Two C-terminal sequences lacking approximately one-quarter of the T-protein’s N-terminal region were expressed (T/93–373 and T/96–373; entries 2–3, Table 3) that dis-played significant levels of PDH activity, but no CM activity Xia et al showed that a similar, monofunctional PDH domain could be prepared from the corresponding bifunctional protein in Erwinia herbicola by deleting residues 1–37 [19] Earlier studies on the E coli T-protein had implicated His197 as a key catalytic residue in PDH activity [15] and Arg294 in prephenate binding [20] Both of these residues were included in the sequences of the two PDH-active fragments Fragment T/101–373 (entry 4, Table 3) was devoid of PDH activity, suggesting that one or more residues in the 97–100 region may play an important role in catalysis

Of the fragments displaying monofunctional PDH acti-vity, analysis of one (T/93–373) by gel exclusion HPLC showed it to be a homodimer (Table 4) As the CM-active fragment T/1–94 was also a homodimer, these data indi-cated that noncovalent interactions resulting in T-protein dimerization appeared to be present in both the CMand PDH domains, unlike the P-protein, in which dimerizing interactions occurred only in the N-terminal region Sam-ples of both T/93–373 and T/96–373 retained > 95% of their activity when stored for 7 days at )70 C and reassayed However, both fragments underwent denatura-tion after prolonged storage (3–4 months at)20 C), with complete loss of activity

With an N-terminal CMsite joined to a PDH domain, the overall layout of chorismate and prephenate processing sites in the T-protein resembled that of the P-protein However, results from the present study showed that the organization of the structural domains responsible for end product inhibition differed substantially in the two bifunctional proteins Whereas the C-terminal 100 residues

of the P-protein constituted a discrete Phe-binding domain, T-protein fragment analysis indicated that tyrosine binding and feedback inhibition could not be attributed to a structural domain that was separate from the CMand PDH domains Initial attempts to pinpoint the C-terminal boundary of the PDH domain established that even minor deletions of C-terminal residues resulted in complete loss of PDH activity (entries 5–8, Table 3) Corresponding residue deletions in the P-protein did not diminish PDT activity

Trang 7

Because of the absence of a discrete regulatory domain

in the T–protein, the interaction of various fragments with

Tyr was investigated to determine whether the Tyr binding

site overlapped with one or more catalytic domains in

the T-protein Tyr had no effect on the low CMactivity

observed in fragments T/1–88, T/1–94, T/1–108, T/1–276,

T/1–296, and T/1–316 However, the CMactivity of

fragment T/1–336 was mildly enhanced at low Tyr

concentrations (up to 10 lM) A similar activation of

CMactivity in the WT T-protein was first observed by

Christopherson at up to 300 lM Tyr [21] for which no

mechanistic rationale has been proposed The fact that

activation by Tyr was weaker in T/1–336 suggested that

the C-terminal 30 residues of the T-protein affected Tyr

binding, and perhaps contributed to an allosteric effect on

CM Overall, the behavior of N-terminal fragments listed

in Table 3 towards Tyr consistently indicated that the

locus of Tyr binding included residues near the C-terminus

of the T-protein

In agreement with that prediction, Tyr had a pronounced

inhibitory effect on PDH-active fragments T/93–373 and

T/96–373 In each case, 50% inhibition of enzyme activity

was observed at 25 ± 5 lM, which agreed with the IC50

value of 20 lM first reported by Koch et al for the WT

T-protein [22] Overall, these findings indicated that Tyr

binding coincided with the region of the T-protein

princi-pally associated with PDH activity, and provide a physical

basis for the observation of Christopherson [21] that Tyr

exerted a more pronounced effect on PDH activity than on

CMactivity Koch et al [16] had earlier proposed a form of

sequential feedback inhibition in which Tyr acted primarily

to inhibit PDH, resulting in an accumulation of prephenate

that, in turn, inhibited CM That picture is consistent with

the physical layout of catalytic and binding sites that

emerges from the T-protein fragment studies presented

here

The domain mapping studies reported here, based on 14

T-protein fragments, indicated that CMand PDH were

separable into independent enzymatic sites, although the

efficiency of the CM-active fragments was considerably

diminished when compared to the native T-protein

Acknowledgements

This work was supported by grants from the National Institutes

of Health (GM24054, to BG) and the Department of Energy

(DE-F G02-84ER13233, to DBW).

References

1 Koch, G.L., Shaw, D.C & Gibson, F (1971) Characterisation of

the subunits of chorismate mutase-prephenate dehydrogenase

from E coli K12 Biochim Biophys Acta 229, 805–812.

2 Haslam, E (1993) Shikimic Acid Metabolism and Metabolites.

John Wiley & Sons, New York, USA.

3 Hudson, G.S., Howlett, G.J & Davidson, B.E (1983) The binding

of tyrosine and NAD+to chorismate mutase/prephenate

dehy-drogenase from Escherichia coli K12 and the effects of these

lig-ands on the activity and self association of the enzyme J Biol.

Chem 258, 3114–3120.

4 Pohnert, G., Zhang, S., Husain, A., Wilson, D.B & Ganem, B.

(1999) Regulation of phenylalanine biosynthesis Calorimetric

studies on the E coli P-protein and its regulatory domain Bio-chemistry 38, 12212–12217.

5 Zhang, S., Pohnert, G., Kongsaeree, P., Wilson, D.B., Clardy, J & Ganem, B (1998) Chorismate mutase-prephenate dehydratase from Escherichia coli: study of catalytic and regulatory domains using genetically engineered proteins J Biol Chem 273, 6248– 6253.

6 Zhang, S., Wilson, D.B & Ganem, B (2000) Probing the catalytic mechanism of prephenate dehydratase by site-directed mutagen-esis of the Escherichia coli P-protein dehydratase domain Biochemistry 39, 4722–4728.

7 Lee, A.Y., Stewart, J.D., Clardy, J & Ganem, B (1995) New insight into the catalytic mechanism of chorismate mutases from structural studies Chem Biol 2, 195–203.

8 Heyde, E & Morrison, J.F (1978) Kinetic studies on the reactions catalyzed by chorismate mutase-prephenate dehydrogenase from Aerobacter aerogenes Biochemistry 17, 1573–1580.

9 Turnbull, J & Morrison, J.F (1990) Chorismate mutase-prephenate dehydrogenase from Escherichia coli 2 Evidence for two different active sites Biochemistry 29, 10255–10261.

10 Turnbull, J., Cleland, W.W & Morrison, J.F (1991) pH dependency of the reactions catalyzed by chorismate mutase-prephenate dehydrogenase from Escherichia coli Biochemistry 30, 7777–7782.

11 Christopherson, R.I (1997) Partial inactivation of chorismate mutase-prephenate dehydrogenase from Escherichia coli in the presence of analogs of chorismate Int J Biochem Cell Biol 29, 589–594.

12 Vincent, S., Chen, S., Wilson, D.B & Ganem, B (2002) Probing the overlap of chorismate mutase and prephenate dehydrogenase sites in the Escherichia coli T-protein: a dehydrogenase-selective inhibitor Bioorg Med Chem Lett 12, 929–931.

13 Zurawski, G., Brown, K., Killingly, D & Yanofsky, C (1978) Nucleotide sequence of the leader region of the phenylalanine operon of Escherichia coli Proc Natl Acad Sci USA 75, 4271– 4275.

14 Davidson, B.E & Hudson, G.S (1987) Chorismate mutase-prephenate dehydrogenase from Escherichia coli Methods Enzymol 142, 440–450.

15 Christendat, D., Saridakis, V.C & Turnbull, J.L (1998) Use of site-directed mutagenesis to identify residues specific for each reaction catalyzed by chorismate mutase-prephenate dehydro-genase from Escherichia coli Biochemistry 37, 15703–15712.

16 Koch, G.L.E., Shaw, D.C & Gibson, F (1972) Studies on the relationship between the active sites of chorismate mutase-prephenate dehydrogenase from Escherichia coli or Aerobacter aerogenes Biochim Biophys Acta 258, 719–730.

17 Llewellyn, D.J & Smith, G.D (1979) Study of chorismate mutase-prephenate dehydrogenase in crude cell extracts of Escherichia coli Biochemistry 18, 4707–4714.

18 Dopheide, T.A.A., Crewther, P & Davidson, B.E (1972) Choris-mate mutase-prephenate dehydratase from Escherichia coli K12.

J Biol Chem 247, 4447–4452.

19 Xia, T., Zhao, G., Fischer, R.S & Jensen, R.A (1992) J General Microbiol 138, 1309–1316.

20 Christendat, D & Turnbull, J.L (1999) Identifying groups involved in the binding of prephenate to prephenate dehydro-genase from Escherichia coli Biochemistry 38, 4782–4793.

21 Christopherson, R.I (1985) Chorismate mutase-prephenate dehydrogenase from Escherichia coli: cooperative effects and inhibition by 1-tyrosine Arch Biochem Biophys 240, 646–654.

22 Koch, G.L.E., Shaw, D.C & Gibson, F (1971) The purification and characterisation of chorismate mutase-prephenate dehydro-genase from Escherichia coli Biochim Biophys Acta 229, 795– 812.

Ngày đăng: 31/03/2014, 07:20

TỪ KHÓA LIÊN QUAN

TÀI LIỆU CÙNG NGƯỜI DÙNG

TÀI LIỆU LIÊN QUAN

🧩 Sản phẩm bạn có thể quan tâm